Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Cohort Analysis
55%
Prevalence
26%
Diabetic Neuropathy
22%
Glucagon-Like Peptide-1 Agonist
22%
Diabetes
21%
Patient with Type 2 Diabetes
19%
Apoplexy
16%
Drug Therapy
16%
Microvascular Complication
16%
Neuropathy
14%
Nephropathy
13%
Physical Activity
13%
Hazard Ratio
11%
Polyneuropathy
11%
Kidney Injury
11%
Acute Kidney Injury
11%
Gastrointestinal Surgery
11%
Cell Function
11%
Insulin Sensitivity
11%
Leisure-Time Physical Activity
11%
UK Biobank
11%
Venous Thromboembolism
11%
Cancer Surgery
11%
Colorectal Cancer
11%
Alcohol Consumption
11%
Multiple Chronic Conditions
11%
Recurrent Disease
11%
Chronic Kidney Disease
11%
Urogenital Tract Infection
11%
Cotransporter
11%
Cardiovascular Disease
10%
Retinopathy
9%
Triacylglycerol
7%
Smoking
7%
Genital Tract Infection
6%
Urinary Tract Infection
6%
Bleeding
5%
Myocardial Infarction
5%
Mental Health
5%
Neurologic Disease
5%
Chronic Lung Disease
5%
Malignant Neoplasm
5%
Obesity
5%
Health Care Utilization
5%
Socioeconomic Status
5%
Cardiovascular System
5%
Insulin Resistance
5%
Low Density Lipoprotein Cholesterol
5%
Hemoglobin A1c
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
87%
Non Insulin Dependent Diabetes Mellitus
67%
Non Insulin Dependent Diabetes Mellitus
44%
Statin (Protein)
23%
Diabetic Neuropathy
22%
Chronic Kidney Failure
22%
Glucagon Like Peptide 1 Receptor Agonist
22%
Triacylglycerol
16%
Ethanol
13%
Kidney Disease
13%
Neuropathy
12%
Venous Thromboembolism
11%
Colorectal Cancer
11%
Polyneuropathy
11%
Multiple Chronic Conditions
11%
Recurrent Disease
11%
Sodium Glucose Cotransporter 2 Inhibitor
11%
Urogenital Tract Infection
11%
Cotransporter
11%
Retinopathy
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Heart Infarction
7%
Genital Tract Infection
6%
Urinary Tract Infection
6%
Cardiovascular Disease
6%
Bleeding
5%
Malignant Neoplasm
5%
Neurologic Disease
5%
Chronic Lung Disease
5%
Obesity
5%
Brain Ischemia
5%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
44%
Prevalence Study
22%
Infection Risk
14%
Diabetes Subgroups
11%
Cohort Profile
11%
Biobank
11%
Strategic Research
11%
Hyperinsulinemic
11%
Pharmacological Treatment
11%
Educational Inequality
11%
Clinical Presentation
11%
Early-type
11%
Self-rated Health
11%
Venous Thromboembolism
11%
Survivors
11%
Glucagon-like
11%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
11%
Urogenital Infections
11%
Receptor Agonist
11%
Routine Care
11%
A1 Receptor
11%
Vascular Complications
9%
Recently Diagnosed
7%
High Educational Level
7%
Insulin Sensitivity
7%
β-cell Function
7%
Urinary Tract Infection
6%
Reproductive Tract Infections
6%
Hemoglobin A1c (HbA1c)
6%
LDL Cholesterol
6%
Insulin Resistance
5%